Here we present a case study of a woman with HER2-positive breast cancer that, after chemotherapy and radiotherapy, followed a Healthful Predominantly Plant-basedDiet. This work aimed to investigate IGF-1 plasma levels modulation through this eating pattern.For 210 days, diet was based on regular...
Foods to eat and avoid for HER2+ patients and survivorsFoods to eat and avoid for inflammatory breast cancer patients & survivorsAll breast cancer patients should take into account their ER/PR subtype in designing their diets:Hormone receptor positive (ER+/PR+) breast cancer...
The researchers didn't know whether the women's tumors were HER2-positive or HER2-negative. (HER2-positive cancers have a faulty HER2 gene that causes breast cells to grow out of control.) But the researchers said some of the women with ER-negative and PR-negative cancers were probably nega...
et al. Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial. Lancet ...
‘Give Yourself Grace’ After a Cancer Diagnosis, Kristen Dahlgren Says Side Effects to Know About for Enhertu in HER2-Positive Solid Tumors ‘Key Signs’ of Cytokine Release Syndrome to Know What to Expect: Hormonal Side Effects from Breast Cancer TreatmentRelated...
A MODERATELY LOWER CARB DIET EFFICIENCY DURING ER /PR±/HER2 BREAST CANCER CHEMOTHERAPY Acta Medica MarisiensisViorela-Diana, ArteneCristian, BordeaAlexandru, Blidaru
significantly diminished the risk of colorectal and receptor-positive breast cancer [185]. However, the practical limit of this study is the unease of applying this therapeutic approach to healthy people in the absence of cardiovascular risk. On the other hand, use of monoclonal antibodies against ...
In contrast, a study from 2010 addressing the effect of micronutrients on postmenopausal breast cancer found a positive association between high dietary folate and the risk of oestrogen receptor- and progesterone receptor-positive breast cancer (Roswall et al, 2010). We found in the present study ...
Short-term fasting protects tumor-bearing mice against the toxic effects of chemotherapy while enhancing therapeutic efficacy. We randomized 131 patients with HER2-negative stage II/III breast cancer, without diabetes and a BMI over 18 kg m−2, to receive either a fasting mimicking diet (FM...
The expression of HMGCR was heterogeneous in the breast cancer cell lines and tissues, and a positive reactivity was seen in the liver, as expected. Therefore, this antibody was used for IHC analyses of HMGCR expression on the TMA, including all incident breast cancers from the MDCS, as ...